Gary J. Richmond
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 25
- HIV/AIDS Research and Interventions 3
- Virology 10
- HIV Research and Treatment 10
- Co-authors
- Jeffrey Fessel (3 shared papers)Edwin DeJesus (8 shared papers)Donald P. Kotler (3 shared papers)Daniel Berger (4 shared papers)Princy N. Kumar (3 shared papers)Shannon Schrader (3 shared papers)Brinda Emu (2 shared papers)Steven P. Weinheimer (3 shared papers)
- Journals
- Open Forum Infectious Diseases (5 papers)The Journal of Infectious Diseases (4 papers)New England Journal of Medicine (4 papers)The Lancet HIV (4 papers)The Lancet (3 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Gary J. Richmond
45 papers receiving 3.9k citations
Gary J. Richmond's Hit Papers
Peers
Comparison fields: 5 of 113
- Virology 1.7k
- Infectious Diseases 2.8k
- Emergency Medicine 515
- Hepatology 126
- Epidemiology 495
Countries citing papers authored by Gary J. Richmond
This map shows the geographic impact of Gary J. Richmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Richmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Richmond more than expected).
Fields of papers citing papers by Gary J. Richmond
This network shows the impact of papers produced by Gary J. Richmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Richmond. The network helps show where Gary J. Richmond may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary J. Richmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study Hit paper breakdown → | 2013 | 445 |
| 2 | 2020 | 431 | |
| 3 | Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial Hit paper breakdown → | 2017 | 429 |
| 4 | Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study Hit paper breakdown → | 2020 | 286 |
| 5 | 2014 | 279 | |
| 6 | 2012 | 264 | |
| 7 | Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection Hit paper breakdown → | 2022 | 223 |
| 8 | 2018 | 179 | |
| 9 | 2007 | 163 | |
| 10 | 2018 | 139 | |
| 11 | 2020 | 117 | |
| 12 | 2021 | 117 | |
| 13 | 2023 | 89 | |
| 14 | 2005 | 82 | |
| 15 | 2017 | 81 | |
| 16 | 2021 | 71 | |
| 17 | 2003 | 66 | |
| 18 | 2014 | 66 | |
| 19 | 2008 | 61 | |
| 20 | 2023 | 54 |
About Gary J. Richmond
Gary J. Richmond is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Hepatology and Epidemiology, having authored 46 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (10 papers), HIV-related health complications and treatments (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS Research and Interventions (3 papers), Hepatitis C virus research (3 papers), Semantic Web and Ontologies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Virology (1.7k citations), Infectious Diseases (2.8k citations), Emergency Medicine (515 citations), Hepatology (126 citations) and Epidemiology (495 citations). Gary J. Richmond has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Jeffrey Fessel, Edwin DeJesus, Donald P. Kotler, Daniel Berger, Princy N. Kumar, Shannon Schrader, Brinda Emu, Steven P. Weinheimer, Christian Marsolais and Stanley T. Lewis. Their work appears in journals such as Open Forum Infectious Diseases, The Journal of Infectious Diseases, New England Journal of Medicine, The Lancet HIV and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.